CytomX Therapeutics
CTMX
CTMX
134 hedge funds and large institutions have $315M invested in CytomX Therapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3.05% less ownership
Funds ownership: 85.28% → 82.23% (-3.1%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
134
Holding in Top 10
–
Calls
–
Puts
$5K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.1M | |
| 3 | +$6.8M | |
| 4 |
RI
RTW Investments
New York
|
+$3.73M |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$3.11M |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$6.72M | |
| 3 | -$6.56M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.02M |
| 5 |
PA
Perceptive Advisors
New York
|
-$5.64M |